List of Excipients in API latanoprostene bunod
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing latanoprostene bunod
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch & Lomb Incorporated | VYZULTA | latanoprostene bunod | 24208-504 | BENZALKONIUM CHLORIDE | |
| Bausch & Lomb Incorporated | VYZULTA | latanoprostene bunod | 24208-504 | EDETATE SODIUM | |
| Bausch & Lomb Incorporated | VYZULTA | latanoprostene bunod | 24208-504 | GLYCERIN | |
| Bausch & Lomb Incorporated | VYZULTA | latanoprostene bunod | 24208-504 | POLYSORBATE 80 | |
| Bausch & Lomb Incorporated | VYZULTA | latanoprostene bunod | 24208-504 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing latanoprostene bunod
Detailed excipient profiles for latanoprostene bunod
Excipient focus: ANHYDROUS CITRIC ACID
latanoprostene bunod drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| >Company | >Ingredient | >NDC |
Excipient focus: BENZALKONIUM CHLORIDE
latanoprostene bunod drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE SODIUM
latanoprostene bunod drug variants containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing EDETATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
latanoprostene bunod drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
latanoprostene bunod drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
latanoprostene bunod drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
latanoprostene bunod drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Bausch & Lomb Incorporated | latanoprostene bunod | 24208-504 |
| Gland Pharma Limited | latanoprostene bunod ophthalmic solution, 0.024% | 68083-563 |
| >Company | >Ingredient | >NDC |
latanoprostene bunod drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
